East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Etodolac Tablets USP, 400 mg and 500 mg. Aurobindo Pharma’s Etodolac Tablets USP, are an AB-rated generic equivalent to the reference listed drug (RLD), Lodine® Tablets, manufactured by Wyeth Pharmaceuticals Inc. Etodolac […] The post Aurobindo Receives FDA Approval for Etodolac Tablets USP, 400 mg and 500 mg appeared first on Aurobindo Pharma USA .